Bigul

Caplin Point Laboratories Ltd - 524742 - Statement Of Investor Complaints For The Quarter Ended March 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 202452596 Name of the Signatory :- Avaneesh SinghDesignation :- Any Other
16-04-2021
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Certificate Pursuant To Regulation 40(9} Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements} Regulations. 2015

Certificate pursuant to Regulation 40(9} of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements} Regulations. 2015
16-04-2021
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Intimation pursuant to Regulation 39(3) of SEBI (LODR) Regulations. 2015
13-04-2021
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Compliance Certificate Pursuant To Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations. 201 S

Compliance certificate pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. 201 S
13-04-2021

Buy Caplin Point Laboratories; target of Rs 605: ICICI Direct

ICICI Direct is bullish on Caplin Point Laboratories has recommended buy rating on the stock with a target price of Rs 605 in its research report dated February 05, 2021.
15-02-2021
Bigul

CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Cessation

Intimation pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 - Resignation of Company Secretary
05-02-2021
Next Page
Close

Let's Open Free Demat Account